CA9 and breast cancer: CAIX inhibitors similarly enhanced radiation sensitivity when used in combination in a breast cancer model; proteomic studies indicated that co-treatment increased expression of pro-apoptotic proteins and reduced expression of anti-apoptotic proteins [66].